AceView: Gene:C16orf42, a comprehensive annotation of human, mouse and worm genes with mRNAs or ESTsAceView.

cDNA accession Links to the sequence	Tissue most 5' clones in red	Match mRNA	From bp to bp in mRNA	From bp to bp in accs.	Clone encodes complete protein (with AA variation)	Features	Anomalies detected by AceView	Accession match over (% length)	Base differences relative to genome (% identity)
AA813462		.a	287 to 583	1 to 297			Submitted on the opposite strand	297/298 (99 %)	34 diff (88.6 %id)
AA302073	aorta	.a	1001 to 1238	1 to 239				239/239 (100 %)	1 diff (99.6 %id)
AA317548	retina	.a	395 to 808	1 to 420				420/420 (100 %)	6 diff (98.6 %id)
AW879681	ovary	.a	813 to 1192	379 to 1				379/379 (100 %)	4 diff (99.0 %id)
AW967078		.a	396 to 1073	1 to 680				680/684 (99 %)	10 diff (98.6 %id)
BC013943	Bone marrow, chronic myelogenous leukemia	.a	36 to 1241	1 to 1206		tiling clone, available from MGC, AAA		1206/1206 (100 %)	4 diff (99.7 %id)
BC016699	Bone marrow, chronic myelogenous leukemia	.a	36 to 1241	1 to 1206		available from MGC, AAA		1206/1206 (100 %)	4 diff (99.7 %id)
BC017325	Lung, large cell carcinoma	.a	56 to 1241	1 to 1186		available from MGC, AAA		1186/1186 (100 %)	1 diff (100.0 %id)
BE075556	breast	.a	695 to 1026	24 to 360				337/360 (93 %)	11 diff (97.0 %id)
BF091959	testis_normal	.b	735 to 1128	1 to 393				393/393 (100 %)	4 diff (99.0 %id)
BF813257	colon_ins	.a	687 to 970	66 to 350				285/350 (81 %)	9 diff (97.5 %id)
BF813854	colon_ins	.a	536 to 1045	32 to 536				505/536 (94 %)	8 diff (98.6 %id)
BF820304	kidney_tumor	.a	797 to 1104	322 to 12			Submitted on the opposite strand	311/322 (96 %)	0 diff (100 %id)
BF883514	lung_tumor	.a	632 to 972	344 to 2			Submitted on the opposite strand	343/348 (98 %)	3 diff (99.2 %id)
BG003692	placenta_normal	.e-u	1 to 237	34 to 263	M2I R3E G4E S5H H6L ...	tiling clone,		230/266 (86 %)	12 diff (95.5 %id)
BG011702	placenta_normal	.e-u	22 to 211	11 to 194		tiling clone,		184/196 (93 %)	13 diff (93.4 %id)
BI013967	lung_tumor	.a	884 to 1196	25 to 335				311/335 (92 %)	6 diff (98.3 %id)
BI064163	uterus_tumor	.a	800 to 1099	299 to 1				299/299 (100 %)	12 diff (96.0 %id)
BI064176	uterus_tumor	.a	797 to 1099	1 to 303				303/303 (100 %)	2 diff (99.4 %id)
BI064262	uterus_tumor	.a	797 to 1099	1 to 303				303/303 (100 %)	0 diff (100 %id)
BI064266	uterus_tumor	.a	797 to 1099	1 to 303				303/303 (100 %)	0 diff (100 %id)
BI064304	uterus_tumor	.a	810 to 1105	14 to 309				296/321 (92 %)	14 diff (95.7 %id)
BI064315	uterus_tumor	.a	797 to 1099	303 to 1				303/303 (100 %)	0 diff (100 %id)
BQ322460	colon_est	.a	724 to 1228	517 to 11				507/523 (96 %)	4 diff (99.3 %id)
BQ332893	lung_tumor	.a	546 to 885	354 to 12				343/354 (96 %)	6 diff (98.4 %id)
DA298781	hippocampus	.b	705 to 1267	22 to 584		tiling clone, capped		563/583 (96 %)	9 diff (98.5 %id)
C00805		.a	810 to 1126	1 to 317				317/317 (100 %)	3 diff (99.1 %id)
CN308506	embryonic stem cells, DMSO-treated H9 cellline	.a	730 to 1241	523 to 12		AAA	Submitted on the opposite strand	512/512 (100 %)	4 diff (99.3 %id)
CN308507	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	.a	283 to 693	1 to 411				411/411 (100 %)	0 diff (100 %id)
CN308508	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	.a	404 to 927	1 to 524				524/524 (100 %)	4 diff (99.3 %id)
CN308509	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	.a	390 to 1024	1 to 635				635/635 (100 %)	2 diff (99.7 %id)
CN308510	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	.a	722 to 1243	527 to 6			Submitted on the opposite strand	522/527 (99 %)	0 diff (100 %id)
CN308511	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	.b	705 to 918	10 to 224				215/224 (95 %)	6 diff (97.4 %id)
CR735860	melanocyte	.a	501 to 1165	1 to 665				665/665 (100 %)	1 diff (99.9 %id)
EC536877	Prostate	.a	844 to 939	1 to 94				96/98 (97 %)	6 diff (93.9 %id)
EL735977	mixed	.a	516 to 1045	1 to 530				530/674 (78 %)	1 diff (99.9 %id)
CD674231	eye, lens	.a	848 to 1241	451 to 58		AAA	Submitted on the opposite strand	394/394 (100 %)	3 diff (99.3 %id)
CD674421	eye, lens	.a	154 to 773	1 to 620				620/620 (100 %)	0 diff (100 %id)
CD674441	eye, lens	.a	143 to 606	1 to 464				464/464 (100 %)	22 diff (95.3 %id)
DB544125. matches multiple genes	hippocampus	.b	708 to 1167	460 to 1			also hits gene BAIAP3	460/462 (99 %)	1 diff (99.8 %id)
DB550952. matches multiple genes	hippocampus	.b	708 to 1227	520 to 1			also hits gene BAIAP3	520/522 (99 %)	0 diff (100 %id)
DB551322. matches multiple genes	hippocampus	.b	709 to 1186	479 to 1			also hits gene BAIAP3	479/482 (99 %)	10 diff (98.0 %id)
BP389878	pancreatic islet	.b	705 to 1063	359 to 1				359/364 (98 %)	0 diff (100 %id)
BQ636546	eye, retina	.a	157 to 721	9 to 573				565/573 (98 %)	8 diff (98.7 %id)
H98014	melanocyte	.a	502 to 887	1 to 383				383/404 (94 %)	17 diff (95.8 %id)
W01878	heart	.a	870 to 1241	372 to 1				372/420 (88 %)	12 diff (97.2 %id)
AA716721	heart	.a	747 to 1242	493 to 1				493/495 (99 %)	11 diff (97.8 %id)
AA258475	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.a	221 to 546	1 to 326			Submitted on the opposite strand	326/326 (100 %)	9 diff (97.3 %id)
AA258690	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.a	860 to 1239	379 to 1			Submitted on the opposite strand	379/379 (100 %)	7 diff (98.2 %id)
AA215709	germinal center B cell	.a	604 to 963	351 to 1			Submitted on the opposite strand	351/351 (100 %)	13 diff (96.3 %id)
AA215710	germinal center B cell	.a	148 to 712	1 to 586			Submitted on the opposite strand	586/588 (99 %)	39 diff (93.4 %id)
AA262869	germinal center B cell	.b	373 to 594	1 to 221				221/221 (100 %)	5 diff (97.8 %id)
AA482458	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.a	861 to 1234	371 to 1			Submitted on the opposite strand	371/371 (100 %)	4 diff (99.0 %id)
AA406408	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.a	278 to 407	1 to 130			Submitted on the opposite strand	130/130 (100 %)	5 diff (96.2 %id)
AA410348	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.a	265 to 665	396 to 1			Submitted on the opposite strand	396/396 (100 %)	11 diff (97.3 %id)
AA481839	ovarian tumor, ovary	.a	857 to 1241	437 to 54		AAA	Submitted on the opposite strand	384/385 (99 %)	7 diff (98.2 %id)
AA543059	colon	.a	287 to 634	1 to 348			Submitted on the opposite strand	348/349 (99 %)	29 diff (91.7 %id)
AA551682	colon	.a	278 to 509	1 to 232			Submitted on the opposite strand	232/232 (100 %)	23 diff (90.1 %id)
AA764863	germinal center B cell	.a	225 to 522	1 to 294			Submitted on the opposite strand	294/294 (100 %)	9 diff (97.0 %id)
AA721110	germinal center B cell	.a	1118 to 1241	150 to 29				122/150 (81 %)	0 diff (100 %id)
AA835659	germinal center B cell	.a	241 to 596	1 to 355				355/355 (100 %)	3 diff (99.2 %id)
AI091298	pooled	.a	166 to 800	1 to 635			Submitted on the opposite strand	635/635 (100 %)	1 diff (99.9 %id)
AI086907	senescent fibroblast	.a	834 to 1241	420 to 13		AAA		408/408 (100 %)	0 diff (100 %id)
AI094880	brain, glioblastoma (pooled)	.a	166 to 635	1 to 470			Submitted on the opposite strand	470/470 (100 %)	0 diff (100 %id)
AI146703	uterus	.a	791 to 1241	450 to 1				450/450 (100 %)	1 diff (99.8 %id)
AI217078	heart	.a	878 to 1242	365 to 1				365/365 (100 %)	0 diff (100 %id)
AI084171	anaplastic oligodendroglioma, brain	.a	148 to 623	1 to 474			Submitted on the opposite strand	474/474 (100 %)	5 diff (99.0 %id)
AI246175	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.a	197 to 662	1 to 466			Submitted on the opposite strand	466/466 (100 %)	11 diff (97.7 %id)
AI224948	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.a	197 to 673	1 to 477			Submitted on the opposite strand	477/478 (99 %)	1 diff (99.8 %id)
AI240952	Kidney	.a	974 to 1241	287 to 20		AAA		268/268 (100 %)	2 diff (99.3 %id)
AI264589	adenocarcinoma, colon	.a	197 to 611	1 to 415			Submitted on the opposite strand	415/415 (100 %)	5 diff (98.8 %id)
AI276183	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.a	166 to 598	1 to 434			Submitted on the opposite strand	434/434 (100 %)	2 diff (99.6 %id)
AI301780	carcinoid, lung	.a	988 to 1240	253 to 1				253/253 (100 %)	1 diff (99.7 %id)
AI304322	adenocarcinoma, colon	.a	334 to 592	1 to 260			Submitted on the opposite strand	260/260 (100 %)	8 diff (97.0 %id)
AI341540		.a	349 to 824	1 to 476			Submitted on the opposite strand	476/476 (100 %)	0 diff (100 %id)
AI264852	borderline ovarian carcinoma, ovary	.a	210 to 449	1 to 240			Submitted on the opposite strand	240/240 (100 %)	0 diff (100 %id)
AI375098		.a	148 to 685	1 to 538			Submitted on the opposite strand	538/539 (99 %)	1 diff (99.9 %id)
AI423636	brain, glioblastoma (pooled)	.a	148 to 593	1 to 446			Submitted on the opposite strand	446/446 (100 %)	0 diff (100 %id)
AI418486	brain, glioblastoma (pooled)	.a	173 to 731	1 to 558			Submitted on the opposite strand	558/558 (100 %)	8 diff (98.6 %id)
AI524203	B-cell, chronic lymphotic leukemia	.a	148 to 731	1 to 584			Submitted on the opposite strand	584/584 (100 %)	6 diff (99.0 %id)
AI435931	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.a	166 to 810	1 to 644			Submitted on the opposite strand	644/644 (100 %)	10 diff (98.5 %id)
AI560264	anaplastic oligodendroglioma, brain	.a	148 to 609	1 to 463			Submitted on the opposite strand	463/464 (99 %)	6 diff (98.8 %id)
AI571317	anaplastic oligodendroglioma, brain	.a	148 to 713	1 to 566			Submitted on the opposite strand	566/566 (100 %)	9 diff (98.5 %id)
AI638343	pooled germ cell tumors	.a	850 to 1241	392 to 1				392/392 (100 %)	0 diff (100 %id)
AI659324	Prostate	.a	148 to 635	1 to 488			Submitted on the opposite strand	488/488 (100 %)	0 diff (100 %id)
AI804998	Prostate	.a	944 to 1241	320 to 23		AAA		298/298 (100 %)	6 diff (98.0 %id)
AI613004	carcinoid, lung	.a	911 to 1243	334 to 3				332/334 (99 %)	0 diff (100 %id)
AI685352	pooled	.a	166 to 633	1 to 466			Submitted on the opposite strand	466/466 (100 %)	2 diff (99.6 %id)
AI684711	pooled	.a	186 to 800	1 to 615			Submitted on the opposite strand	615/615 (100 %)	7 diff (98.9 %id)
AI675241	Prostate	.a	192 to 713	1 to 522			Submitted on the opposite strand	522/531 (98 %)	7 diff (98.7 %id)
AI799802	Prostate	.a	555 to 1243	688 to 2				687/688 (99 %)	8 diff (98.9 %id)
AI693236	carcinoid, lung	.a	590 to 1240	651 to 1				651/653 (99 %)	9 diff (98.7 %id)
AI672681	thymus, pooled	.a	148 to 610	1 to 464			Submitted on the opposite strand	464/464 (100 %)	4 diff (99.2 %id)
AI660316	thymus, pooled	.a	148 to 751	1 to 604			Submitted on the opposite strand	604/604 (100 %)	6 diff (99.1 %id)
AI797628	pooled	.a	278 to 619	1 to 342			Submitted on the opposite strand	342/358 (95 %)	21 diff (94.2 %id)
AI741018	pooled	.a	583 to 1243	666 to 4				663/666 (99 %)	5 diff (99.3 %id)
AI813672	lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic)	.a	148 to 711	1 to 565			Submitted on the opposite strand	565/565 (100 %)	2 diff (99.7 %id)
AI864881	lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic)	.a	197 to 628	1 to 434			Submitted on the opposite strand	434/437 (99 %)	7 diff (98.4 %id)
AI864904	lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic)	.a	196 to 631	1 to 437			Submitted on the opposite strand	437/437 (100 %)	1 diff (99.8 %id)
AI870170	lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic)	.a	278 to 607	1 to 330			Submitted on the opposite strand	330/331 (99 %)	30 diff (91.0 %id)
AI927360	lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic)	.a	148 to 615	1 to 468			Submitted on the opposite strand	468/470 (99 %)	17 diff (96.4 %id)
AI925218	lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic)	.a	184 to 773	1 to 590			Submitted on the opposite strand	590/590 (100 %)	4 diff (99.4 %id)
AI923651	lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic)	.a	148 to 662	1 to 515			Submitted on the opposite strand	515/515 (100 %)	0 diff (100 %id)
AI970378	pooled germ cell tumors	.a	871 to 1243	374 to 2				373/375 (99 %)	0 diff (100 %id)
AW007556	colon	.a	148 to 791	1 to 644			Submitted on the opposite strand	644/644 (100 %)	1 diff (99.9 %id)
AW007602	colon	.a	166 to 791	1 to 627			Submitted on the opposite strand	627/627 (100 %)	5 diff (99.3 %id)
AI982580	pooled germ cell tumors	.a	1114 to 1241	146 to 19		AAA		128/128 (100 %)	6 diff (95.4 %id)
AI971937	fibrotheoma, ovary	.a	148 to 610	1 to 464			Submitted on the opposite strand	464/464 (100 %)	1 diff (99.8 %id)
AI971966	fibrotheoma, ovary	.a	166 to 610	1 to 446			Submitted on the opposite strand	446/446 (100 %)	1 diff (99.8 %id)
AI972013	fibrotheoma, ovary	.a	148 to 599	1 to 452			Submitted on the opposite strand	452/452 (100 %)	3 diff (99.4 %id)
AI951731	fibrotheoma, ovary	.a	192 to 767	1 to 576			Submitted on the opposite strand	576/576 (100 %)	3 diff (99.5 %id)
AW057975	thymus, pooled	.a	148 to 593	1 to 451			Submitted on the opposite strand	451/451 (100 %)	5 diff (98.9 %id)
AW083808	colon, moderately differentiated adenocarcinoma	.a	816 to 1243	430 to 3				428/430 (99 %)	1 diff (99.8 %id)
AW088075	brain, tumor, 5 pooled (see description)	.a	178 to 429	1 to 253			Submitted on the opposite strand	253/254 (99 %)	6 diff (97.7 %id)
AW014117		.a	149 to 408	1 to 260			Submitted on the opposite strand	260/260 (100 %)	3 diff (98.9 %id)
AW340952	carcinoid, lung	.a	632 to 1240	609 to 1				609/611 (99 %)	2 diff (99.7 %id)
AW340975	carcinoid, lung	.a	632 to 1243	613 to 2				612/618 (99 %)	12 diff (98.1 %id)
AW341301	carcinoid, lung	.a	148 to 767	1 to 620			Submitted on the opposite strand	620/620 (100 %)	1 diff (99.9 %id)
AW733086	Kidney, renal cell adenocarcinoma	.a	865 to 1243	386 to 8				379/386 (98 %)	0 diff (100 %id)
AW406663	lymph	.a	852 to 1239	395 to 8			Submitted on the opposite strand	388/395 (98 %)	0 diff (100 %id)
BE048932	Kidney	.a	974 to 1241	283 to 16		AAA		268/268 (100 %)	0 diff (100 %id)
BE328802	carcinoid, lung	.a	166 to 722	1 to 557			Submitted on the opposite strand	557/557 (100 %)	13 diff (97.7 %id)
BE674893	B-cell, chronic lymphotic leukemia	.a	148 to 810	1 to 662			Submitted on the opposite strand	662/662 (100 %)	3 diff (99.6 %id)
BE258153	eye, retinoblastoma	.a	81 to 730	1 to 636				636/716 (88 %)	30 diff (95.9 %id)
BF439696	brain, glioblastoma (pooled)	.a	831 to 1041	211 to 1				211/211 (100 %)	4 diff (98.2 %id)
BF439903	brain, glioblastoma (pooled)	.a	871 to 1041	171 to 1				171/175 (97 %)	8 diff (95.5 %id)
BF058171	fibrotheoma, ovary	.a	152 to 352	1 to 202			Submitted on the opposite strand	202/202 (100 %)	7 diff (96.6 %id)
BF196333	fibrotheoma, ovary	.a	148 to 850	1 to 700			Submitted on the opposite strand	700/701 (99 %)	17 diff (97.6 %id)
BF222112	Prostate	.a	786 to 1036	256 to 6				251/256 (98 %)	3 diff (98.9 %id)
BC011785	Ovary, adenocarcinoma	.a	78 to 1241	1 to 1163		tiling clone, available from MGC, AAA		1163/1163 (100 %)	2 diff (99.9 %id)
BE747038	adenocarcinoma cell line, ovary	.a	99 to 810	1 to 698		available from MGC,		698/818 (85 %)	28 diff (96.6 %id)
BE792494	lung, small cell carcinoma	.a	61 to 875	1 to 811				809/1196 (67 %)	20 diff (98.4 %id)
BE741626	adenocarcinoma cell line, ovary	.a	134 to 858	1 to 717				717/721 (99 %)	12 diff (98.4 %id)
BF131571	hypernephroma, Kidney	.a	764 to 1238	1 to 475				475/649 (73 %)	11 diff (98.4 %id)
BF211141	bone marrow, from chronic myelogenous leukemia	.a	39 to 449	1 to 413				413/491 (84 %)	50 diff (89.9 %id)
BF219262	brain, glioblastoma	.a	41 to 642	1 to 604				604/724 (83 %)	21 diff (97.1 %id)
BF207312	brain, neuroblastoma	.a	62 to 606	1 to 566				566/865 (65 %)	38 diff (95.7 %id)
BG271361	normal head/neck tissue	.a	1096 to 1243	150 to 3				148/173 (85 %)	0 diff (100 %id)
BF688877	eye, normal pigmented retinal epithelium	.a	532 to 1198	707 to 35				673/708 (95 %)	3 diff (99.6 %id)
BF974746	B-cells, primary B-cells from tonsils (cell line)	.a	229 to 1074	1 to 846				846/1131 (74 %)	39 diff (96.6 %id)
BG332160	large cell carcinoma, lung	.a	56 to 812	1 to 746				746/882 (84 %)	72 diff (91.9 %id)
BG339128	leiomyosarcoma cell line, uterus	.a	64 to 805	1 to 745				745/939 (79 %)	20 diff (97.9 %id)
BG338976	leiomyosarcoma cell line, uterus	.a	823 to 1241	1 to 419				419/655 (63 %)	3 diff (99.6 %id)
BG339919	leiomyosarcoma cell line, uterus	.a	823 to 1241	1 to 418		AAA		418/418 (100 %)	5 diff (98.9 %id)
BG500856	adenocarcinoma, Prostate	.a	1 to 643	1 to 638		tiling clone,		638/640 (99 %)	19 diff (97.1 %id)
BG530555	embryonal carcinoma, testis	.a	49 to 819	1 to 772				772/841 (91 %)	24 diff (97.2 %id)
BG709543	brain, hypothalamus	.a	76 to 810	1 to 729				729/758 (96 %)	21 diff (97.3 %id)
BI160048	epithelioid carcinoma cell line, Pancreas	.a	147 to 875	1 to 733				732/742 (98 %)	13 diff (98.3 %id)
BI597366	brain, hypothalamus	.a	76 to 684	1 to 609				609/609 (100 %)	9 diff (98.6 %id)
BM459604	leiomyosarcoma, uterus	.b	63 to 718	35 to 692		tiling clone,		658/977 (67 %)	20 diff (98.0 %id)
BI793021	Islets of Langerhans, Pancreas	.a	666 to 1243	584 to 7				578/584 (98 %)	0 diff (100 %id)
BI793329	Islets of Langerhans, Pancreas	.a	547 to 1121	1 to 575				575/575 (100 %)	0 diff (100 %id)
CK821140	Islets of Langerhans, Pancreas	.a	663 to 1243	587 to 7				581/587 (98 %)	0 diff (100 %id)
CK821141	Islets of Langerhans, Pancreas	.a	531 to 1126	1 to 596				596/596 (100 %)	0 diff (100 %id)
BI789155	Islets of Langerhans, Pancreas	.a	844 to 1243	406 to 7		fully sequenced,		400/406 (98 %)	0 diff (100 %id)
BI962632	Islets of Langerhans, Pancreas	.a	547 to 905	1 to 359		fully sequenced,		359/359 (100 %)	0 diff (100 %id)
BM903585	ovary (pool of 3)	.d-u	1 to 561	13 to 573	exact	tiling clone, AAA		561/612 (91 %)	1 diff (99.9 %id)
CB409217	maxilla, pooled	.a	1041 to 1245	1 to 207				207/207 (100 %)	7 diff (96.7 %id)
BQ014847	Chondrosarcoma, Left Pubic Bone	.a	627 to 1241	631 to 16		AAA		616/634 (97 %)	3 diff (99.6 %id)
CB215914	normal endometrium, late proliferativephase, cycle day 13, uterus	.a	578 to 1162	1 to 585				585/585 (100 %)	0 diff (100 %id)
BQ421397	epithelioid carcinoma, Pancreas	.a	305 to 1121	1 to 830				830/880 (94 %)	24 diff (97.3 %id)
BU070467	insulinoma, Pancreas	.a	619 to 1238	641 to 17		AAA		625/631 (99 %)	24 diff (96.2 %id)
BU501444	eye, normal pigmented retinal epithelium	.a	440 to 1188	1 to 756				756/964 (78 %)	48 diff (95.1 %id)
CD172433	White Matter	.a	389 to 1233	1 to 851				851/855 (99 %)	11 diff (98.8 %id)
CD557049	brain, Pituitary	.a	816 to 1241	1 to 426		AAA		426/426 (100 %)	3 diff (99.3 %id)
CD519611	White Matter	.a	815 to 1241	8 to 434		AAA		427/434 (98 %)	6 diff (98.7 %id)
CF126839	Chondrosarcoma Lung Metastasis cell lines, lung	.a	61 to 178	1 to 117				117/117 (100 %)	5 diff (95.8 %id)
TI_45216140		.a	79 to 684	125 to 730				606/730 (83 %)	10 diff (98.7 %id)
NM_001001410.2		.a	40 to 1241	1 to 1202		RefSeq, AAA		1202/1202 (100 %)	0 diff (100 %id)
BM846293	myeloma	.a	173 to 715	1 to 541				541/541 (100 %)	9 diff (98.4 %id)
F31747	pectoral muscle (after mastectomy)	.a	953 to 1035	1 to 83				83/83 (100 %)	1 diff (98.8 %id)
TI_1948236622		.a	516 to 1045	1133 to 602			Submitted on the opposite strand	532/1448 (36 %)	25 diff (98.3 %id)
TI_1948236623		.a	632 to 1045	1023 to 608			Submitted on the opposite strand	416/1236 (33 %)	9 diff (99.3 %id)
TI_1948236796		.a	722 to 1045	931 to 603			Submitted on the opposite strand	329/1291 (25 %)	22 diff (98.3 %id)
TI_1948236968		.a	632 to 1045	1015 to 606			Submitted on the opposite strand	410/1260 (32 %)	22 diff (98.3 %id)
TI_1948237154		.a	738 to 1045	903 to 599			Submitted on the opposite strand	305/1412 (21 %)	15 diff (99.0 %id)
DN994322	brain, whole brain	.a	43 to 433	1 to 391				391/391 (100 %)	5 diff (98.8 %id)
TI_149291670		.a	559 to 1241	781 to 99		AAA		683/683 (100 %)	3 diff (99.6 %id)
TI_149298264		.a	477 to 1241	867 to 113		AAA		755/901 (83 %)	10 diff (98.9 %id)
TI_149312613		.a	633 to 1241	693 to 85		AAA		609/983 (61 %)	0 diff (100 %id)
TI_154045030		.a	460 to 1241	856 to 84		AAA		773/974 (79 %)	8 diff (99.2 %id)
TI_154090397		.a	148 to 706	59 to 620			Submitted on the opposite strand	562/1224 (45 %)	25 diff (98.0 %id)
TI_154142504		.a	811 to 1238	524 to 97		AAA	Submitted on the opposite strand	428/748 (57 %)	5 diff (99.4 %id)
TI_154144253		.a	717 to 1239	609 to 83			Submitted on the opposite strand	527/531 (99 %)	12 diff (97.8 %id)
TI_154145327		.b	357 to 877	640 to 120			Submitted on the opposite strand	521/788 (66 %)	7 diff (99.2 %id)
TI_154146479		.b	357 to 870	605 to 89			Submitted on the opposite strand	517/600 (86 %)	13 diff (97.9 %id)
TI_157600266		.a	148 to 994	54 to 884			Submitted on the opposite strand	833/886 (94 %)	25 diff (97.2 %id)
TI_159679422		.b	1 to 902	990 to 99	L4*	tiling clone, AAA		892/1028 (86 %)	25 diff (97.6 %id)
TI_159687966		.b	318 to 902	689 to 104		AAA		586/1005 (58 %)	11 diff (99.0 %id)
TI_159691170		.c	1 to 779	916 to 152	R2E L3S L4A G5P R6I ...	tiling clone, AAA		765/1112 (68 %)	23 diff (98.0 %id)
BU682109	lung	.a	632 to 1241	628 to 19		AAA		610/617 (98 %)	1 diff (99.9 %id)
BM978170	lung	.a	633 to 1241	624 to 16		AAA		609/616 (98 %)	0 diff (100 %id)
BM983033	lung, Primary Lung Cystic Fibrosis EpithelialCells	.a	625 to 1241	632 to 16		AAA		617/617 (100 %)	0 diff (100 %id)
BM688608	eye, eye anterior segment	.a	752 to 1178	9 to 435				427/435 (98 %)	3 diff (99.4 %id)
BM670317	eye, lens	.a	828 to 1241	429 to 16		fully sequenced, AAA		414/414 (100 %)	0 diff (100 %id)
BM712037	eye, lens	.a	445 to 858	1 to 414		fully sequenced,		414/414 (100 %)	0 diff (100 %id)
BM679893	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.a	894 to 1242	368 to 19		fully sequenced, AAA		350/350 (100 %)	4 diff (98.9 %id)
BM728236	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.a	496 to 924	1 to 428		fully sequenced,		428/428 (100 %)	3 diff (99.3 %id)
CA411917	Chondrosarcoma Grade II, Left Pelvis	.a	624 to 1241	636 to 19		AAA		618/618 (100 %)	0 diff (100 %id)
BU621274	cell lines, Chondrosarcoma	.a	620 to 1241	640 to 19		AAA		622/622 (100 %)	1 diff (99.9 %id)
BU634510	cell lines, Chondrosarcoma	.a	625 to 1241	632 to 16		AAA		617/617 (100 %)	1 diff (99.9 %id)
TI_151738223		.a	804 to 1243	574 to 135				440/977 (45 %)	4 diff (99.6 %id)
AI143673	anaplastic oligodendroglioma, brain	.a	823 to 1241	1 to 419			Submitted on the opposite strand, submitted on the opposite strand	419/655 (63 %)	3 diff (99.6 %id)
EB385952	eye, optic nerve	.a	823 to 1241	1 to 419			This clone was ignored	419/655 (63 %)	3 diff (99.6 %id)
BG339919	leiomyosarcoma cell line, uterus	.a	823 to 1241	1 to 418		AAA		418/418 (100 %)	5 diff (98.9 %id)
BG339919	leiomyosarcoma cell line, uterus	.a	823 to 1241	1 to 418		AAA		418/418 (100 %)	5 diff (98.9 %id)
BG500856	adenocarcinoma, Prostate	.a	1 to 643	1 to 638		tiling clone,		638/640 (99 %)	19 diff (97.1 %id)
BG500856	adenocarcinoma, Prostate	.a	1 to 643	1 to 638		tiling clone,		638/640 (99 %)	19 diff (97.1 %id)
BG530555	embryonal carcinoma, testis	.a	49 to 819	1 to 772				772/841 (91 %)	24 diff (97.2 %id)
BG530555	embryonal carcinoma, testis	.a	49 to 819	1 to 772				772/841 (91 %)	24 diff (97.2 %id)
BG709543	brain, hypothalamus	.a	76 to 810	1 to 729				729/758 (96 %)	21 diff (97.3 %id)
BG709543	brain, hypothalamus	.a	76 to 810	1 to 729				729/758 (96 %)	21 diff (97.3 %id)
BI160048	epithelioid carcinoma cell line, Pancreas	.a	147 to 875	1 to 733				732/742 (98 %)	13 diff (98.3 %id)
BI160048	epithelioid carcinoma cell line, Pancreas	.a	147 to 875	1 to 733				732/742 (98 %)	13 diff (98.3 %id)
BI597366	brain, hypothalamus	.a	76 to 684	1 to 609				609/609 (100 %)	9 diff (98.6 %id)
BI597366	brain, hypothalamus	.a	76 to 684	1 to 609				609/609 (100 %)	9 diff (98.6 %id)
BM459604	leiomyosarcoma, uterus	.b	63 to 718	35 to 692		tiling clone,		658/977 (67 %)	20 diff (98.0 %id)
BM459604	leiomyosarcoma, uterus	.b	63 to 718	35 to 692		tiling clone,		658/977 (67 %)	20 diff (98.0 %id)
BI793021	Islets of Langerhans, Pancreas	.a	666 to 1243	584 to 7				578/584 (98 %)	0 diff (100 %id)
BI793021	Islets of Langerhans, Pancreas	.a	666 to 1243	584 to 7				578/584 (98 %)	0 diff (100 %id)
BI793329	Islets of Langerhans, Pancreas	.a	547 to 1121	1 to 575				575/575 (100 %)	0 diff (100 %id)
BI793329	Islets of Langerhans, Pancreas	.a	547 to 1121	1 to 575				575/575 (100 %)	0 diff (100 %id)
CK821140	Islets of Langerhans, Pancreas	.a	663 to 1243	587 to 7				581/587 (98 %)	0 diff (100 %id)
CK821140	Islets of Langerhans, Pancreas	.a	663 to 1243	587 to 7				581/587 (98 %)	0 diff (100 %id)
CK821141	Islets of Langerhans, Pancreas	.a	531 to 1126	1 to 596				596/596 (100 %)	0 diff (100 %id)
CK821141	Islets of Langerhans, Pancreas	.a	531 to 1126	1 to 596				596/596 (100 %)	0 diff (100 %id)
BI789155	Islets of Langerhans, Pancreas	.a	844 to 1243	406 to 7		fully sequenced,		400/406 (98 %)	0 diff (100 %id)
BI789155	Islets of Langerhans, Pancreas	.a	844 to 1243	406 to 7		fully sequenced,		400/406 (98 %)	0 diff (100 %id)
BI962632	Islets of Langerhans, Pancreas	.a	547 to 905	1 to 359		fully sequenced,		359/359 (100 %)	0 diff (100 %id)
BI962632	Islets of Langerhans, Pancreas	.a	547 to 905	1 to 359		fully sequenced,		359/359 (100 %)	0 diff (100 %id)
BM903585	ovary (pool of 3)	.d-u	1 to 561	13 to 573	exact	tiling clone, AAA		561/612 (91 %)	1 diff (99.9 %id)
CB409217	maxilla, pooled	.a	1041 to 1245	1 to 207				207/207 (100 %)	7 diff (96.7 %id)
BQ014847	Chondrosarcoma, Left Pubic Bone	.a	627 to 1241	631 to 16		AAA		616/634 (97 %)	3 diff (99.6 %id)
BQ014847	Chondrosarcoma, Left Pubic Bone	.a	627 to 1241	631 to 16		AAA		616/634 (97 %)	3 diff (99.6 %id)
CB215914	normal endometrium, late proliferativephase, cycle day 13, uterus	.a	578 to 1162	1 to 585				585/585 (100 %)	0 diff (100 %id)
CB215914	normal endometrium, late proliferativephase, cycle day 13, uterus	.a	578 to 1162	1 to 585				585/585 (100 %)	0 diff (100 %id)
BQ421397	epithelioid carcinoma, Pancreas	.a	305 to 1121	1 to 830				830/880 (94 %)	24 diff (97.3 %id)
BQ421397	epithelioid carcinoma, Pancreas	.a	305 to 1121	1 to 830				830/880 (94 %)	24 diff (97.3 %id)
BU070467	insulinoma, Pancreas	.a	619 to 1238	641 to 17		AAA		625/631 (99 %)	24 diff (96.2 %id)
BU070467	insulinoma, Pancreas	.a	619 to 1238	641 to 17		AAA		625/631 (99 %)	24 diff (96.2 %id)
BU501444	eye, normal pigmented retinal epithelium	.a	440 to 1188	1 to 756				756/964 (78 %)	48 diff (95.1 %id)
BU501444	eye, normal pigmented retinal epithelium	.a	440 to 1188	1 to 756				756/964 (78 %)	48 diff (95.1 %id)
CD172433	White Matter	.a	389 to 1233	1 to 851				851/855 (99 %)	11 diff (98.8 %id)
CD557049	brain, Pituitary	.a	816 to 1241	1 to 426		AAA		426/426 (100 %)	3 diff (99.3 %id)
CD557049	brain, Pituitary	.a	816 to 1241	1 to 426		AAA		426/426 (100 %)	3 diff (99.3 %id)
CD519611	White Matter	.a	815 to 1241	8 to 434		AAA		427/434 (98 %)	6 diff (98.7 %id)
CF126839	Chondrosarcoma Lung Metastasis cell lines, lung	.a	61 to 178	1 to 117				117/117 (100 %)	5 diff (95.8 %id)
CF126839	Chondrosarcoma Lung Metastasis cell lines, lung	.a	61 to 178	1 to 117				117/117 (100 %)	5 diff (95.8 %id)
TI_45216140		.a	79 to 684	125 to 730				606/730 (83 %)	10 diff (98.7 %id)
NM_001001410.2		.a	40 to 1241	1 to 1202		RefSeq, AAA		1202/1202 (100 %)	0 diff (100 %id)
BM846293	myeloma	.a	173 to 715	1 to 541				541/541 (100 %)	9 diff (98.4 %id)
F31747	pectoral muscle (after mastectomy)	.a	953 to 1035	1 to 83				83/83 (100 %)	1 diff (98.8 %id)
TI_1948236622		.a	516 to 1045	1133 to 602			Submitted on the opposite strand	532/1448 (36 %)	25 diff (98.3 %id)
TI_1948236623		.a	632 to 1045	1023 to 608			Submitted on the opposite strand	416/1236 (33 %)	9 diff (99.3 %id)
TI_1948236796		.a	722 to 1045	931 to 603			Submitted on the opposite strand	329/1291 (25 %)	22 diff (98.3 %id)
TI_1948236968		.a	632 to 1045	1015 to 606			Submitted on the opposite strand	410/1260 (32 %)	22 diff (98.3 %id)
TI_1948237154		.a	738 to 1045	903 to 599			Submitted on the opposite strand	305/1412 (21 %)	15 diff (99.0 %id)
DN994322	brain, whole brain	.a	43 to 433	1 to 391				391/391 (100 %)	5 diff (98.8 %id)
DN994322	brain, whole brain	.a	43 to 433	1 to 391				391/391 (100 %)	5 diff (98.8 %id)
TI_149291670		.a	559 to 1241	781 to 99		AAA		683/683 (100 %)	3 diff (99.6 %id)
TI_149298264		.a	477 to 1241	867 to 113		AAA		755/901 (83 %)	10 diff (98.9 %id)
TI_149312613		.a	633 to 1241	693 to 85		AAA		609/983 (61 %)	0 diff (100 %id)
TI_154045030		.a	460 to 1241	856 to 84		AAA		773/974 (79 %)	8 diff (99.2 %id)
TI_154090397		.a	148 to 706	59 to 620			Submitted on the opposite strand	562/1224 (45 %)	25 diff (98.0 %id)
TI_154142504		.a	811 to 1238	524 to 97		AAA	Submitted on the opposite strand	428/748 (57 %)	5 diff (99.4 %id)
TI_154144253		.a	717 to 1239	609 to 83			Submitted on the opposite strand	527/531 (99 %)	12 diff (97.8 %id)
TI_154145327		.b	357 to 877	640 to 120			Submitted on the opposite strand	521/788 (66 %)	7 diff (99.2 %id)
TI_154146479		.b	357 to 870	605 to 89			Submitted on the opposite strand	517/600 (86 %)	13 diff (97.9 %id)
TI_157600266		.a	148 to 994	54 to 884			Submitted on the opposite strand	833/886 (94 %)	25 diff (97.2 %id)
TI_159679422		.b	1 to 902	990 to 99	L4*	tiling clone, AAA		892/1028 (86 %)	25 diff (97.6 %id)
TI_159687966		.b	318 to 902	689 to 104		AAA		586/1005 (58 %)	11 diff (99.0 %id)
TI_159691170		.c	1 to 779	916 to 152	R2E L3S L4A G5P R6I ...	tiling clone, AAA		765/1112 (68 %)	23 diff (98.0 %id)
BU682109	lung	.a	632 to 1241	628 to 19		AAA		610/617 (98 %)	1 diff (99.9 %id)
BM978170	lung	.a	633 to 1241	624 to 16		AAA		609/616 (98 %)	0 diff (100 %id)
BM983033	lung, Primary Lung Cystic Fibrosis EpithelialCells	.a	625 to 1241	632 to 16		AAA		617/617 (100 %)	0 diff (100 %id)
BM983033	lung, Primary Lung Cystic Fibrosis EpithelialCells	.a	625 to 1241	632 to 16		AAA		617/617 (100 %)	0 diff (100 %id)
BM688608	eye, eye anterior segment	.a	752 to 1178	9 to 435				427/435 (98 %)	3 diff (99.4 %id)
BM688608	eye, eye anterior segment	.a	752 to 1178	9 to 435				427/435 (98 %)	3 diff (99.4 %id)
BM670317	eye, lens	.a	828 to 1241	429 to 16		fully sequenced, AAA		414/414 (100 %)	0 diff (100 %id)
BM670317	eye, lens	.a	828 to 1241	429 to 16		fully sequenced, AAA		414/414 (100 %)	0 diff (100 %id)
BM712037	eye, lens	.a	445 to 858	1 to 414		fully sequenced,		414/414 (100 %)	0 diff (100 %id)
BM712037	eye, lens	.a	445 to 858	1 to 414		fully sequenced,		414/414 (100 %)	0 diff (100 %id)
BM679893	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.a	894 to 1242	368 to 19		fully sequenced, AAA		350/350 (100 %)	4 diff (98.9 %id)
BM679893	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.a	894 to 1242	368 to 19		fully sequenced, AAA		350/350 (100 %)	4 diff (98.9 %id)
BM728236	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.a	496 to 924	1 to 428		fully sequenced,		428/428 (100 %)	3 diff (99.3 %id)
BM728236	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.a	496 to 924	1 to 428		fully sequenced,		428/428 (100 %)	3 diff (99.3 %id)
CA411917	Chondrosarcoma Grade II, Left Pelvis	.a	624 to 1241	636 to 19		AAA		618/618 (100 %)	0 diff (100 %id)
CA411917	Chondrosarcoma Grade II, Left Pelvis	.a	624 to 1241	636 to 19		AAA		618/618 (100 %)	0 diff (100 %id)
BU621274	cell lines, Chondrosarcoma	.a	620 to 1241	640 to 19		AAA		622/622 (100 %)	1 diff (99.9 %id)
BU621274	cell lines, Chondrosarcoma	.a	620 to 1241	640 to 19		AAA		622/622 (100 %)	1 diff (99.9 %id)
BU634510	cell lines, Chondrosarcoma	.a	625 to 1241	632 to 16		AAA		617/617 (100 %)	1 diff (99.9 %id)
BU634510	cell lines, Chondrosarcoma	.a	625 to 1241	632 to 16		AAA		617/617 (100 %)	1 diff (99.9 %id)
TI_151738223		.a	804 to 1243	574 to 135				440/977 (45 %)	4 diff (99.6 %id)